FOXP3型
白细胞介素2受体
体外
细胞生物学
生物
转录因子
免疫学
体内
免疫疗法
免疫系统
T细胞
遗传学
基因
作者
Massimo Claudio Fantini,Sabine Dominitzki,A. Rizzo,Markus F. Neurath,Christoph Becker
出处
期刊:Nature Protocols
[Springer Nature]
日期:2007-07-01
卷期号:2 (7): 1789-1794
被引量:127
标识
DOI:10.1038/nprot.2007.258
摘要
CD4+ CD25+ regulatory T cells (Tregs) are crucial for the maintenance of immunological tolerance. Recent data indicate that Tregs not only develop in the thymus during ontogeny but can also differentiate from naive T cells in the periphery. The following protocol describes a method by which Tregs are generated in vitro by stimulation of naive T cells in the presence of transforming growth factor beta (Ti-Tregs). In vitro-induced regulatory T cells express markers of conventional Treg such as CD25 and the genetic program committing transcription factor FoxP3. Functionally the in vitro-generated Ti-Tregs suppress T-cell activation and proliferation while in vivo these cells have been proven to control inflammation in different animal models, suggesting a potential use of these cells for immunotherapy. The protocol can be completed within 5 days.
科研通智能强力驱动
Strongly Powered by AbleSci AI